Comparative risk of hepatitis C virus infection in patients with rheumatoid arthritis receiving target-synthetic disease-modified anti-rheumatic drugs (tsDMARDs) versus biological DMARDs (bDMARDs): A population-based study
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY（2023）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要